Order byBest matchMost fresh
HHS slams 'under-tested' mRNA technology as Trump cuts Moderna's vaccine funding
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of oversight around the new mRNA vaccine technology.
BioPharma Dive1h
FDA clears Moderna’s new COVID vaccine, but with limits
The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe disease.
Wyoming Tribune Eagle1d
HHS cancels Moderna’s $590 million contract for bird flu vaccine
U.S. health officials are terminating a $590 million contract with Moderna Inc. to develop vaccines for bird flu, a major setback for the company that’s also facing additional government scrutiny
STAT2d
Pharmalittle: We’re reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and more
In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and more.
Moderna Announces Update on Investigational Pandemic Influenza Program
H5 avian flu vaccine study shows positive interim results Company has been notified that HHS will terminate Moderna’s award for late-stage development of pre-pandemic influenza vaccines CAMBRIDGE, MA / ACCESS Newswire / May 28,
Feedback